Joanne E. Schottinger, MD

Biography

Associate Professor

Health Systems Science

Dr. Joanne Schottinger is a medical oncologist and hematologist who has researched, published, and presented information about the detection, treatment, and prevention of diseases and cancers. Dr. Schottinger has served on committees that explore topics such as cancer screening programs, biotechnology and emerging pharmaceuticals, lifestyle medicine, prevention, health education, and therapeutics.

Education and Training

Degrees: BA, summa cum laude, Boston University
MD, Boston University School of Medicine

Residency: Internship and Residency, Internal Medicine, Saint Elizabeth’s Hospital

Fellowship: Hematology and Medical Oncology, University of California, Irvine

Professional Positions

Medical Oncologist and Hematologist: Kaiser Permanente, Panorama City; 1984-present

Physician in Charge, Oncology Division: Kaiser Permanente, Panorama City; 1992-1998

Medical Staff President: Kaiser Permanente, Panorama City; 1994

Assistant Chief, Internal Medicine: Kaiser Permanente, Panorama City; 1995-1997

Chief of Service, Internal Medicine: Kaiser Permanente, Panorama City; 1999-2002

Regional Assistant Medical Director, Quality and Clinical Analysis: Kaiser Permanente, Southern California Region; 2002-2016

Honors and Awards

Leon Cohen award for distinguished clinician: Panorama City Medical Center; 2002

James A. Vohs Quality Award for Sleepless Nights Timely Breast Cancer Diagnosis Program: Kaiser Permanente; 2006

James A. Vohs Quality Award for Oncology Electronic Record: Kaiser Permanente; 2011

David M. Lawrence Safety Award for Regional Safety Net: Kaiser Permanente; 2012

James A. Vohs Quality Award for Prostate Cancer Care Program: Kaiser Permanente; 2014

Scholarly Activities

Selected peer-reviewed research manuscripts

Kwan ML, Shi JM, Habel LA, Song J, Chung J, Avila CC, Schottinger JE, Cheetham TC, Fletcher SW, Haque R. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Research and Treatment 03/2016;156(2). DOI:10.1007/s10549-016-3763-6.
Jensen CD, Quinn VP, Doubeni CA, Zauber AG, Levin TR, Lee JK, Schottinger JE, Marks AR, Zhao WK, Ghai NR, Lee AT, Contreras R, Quesenberry CP, Fireman BH, Corley D. 175 Colonoscopy Delay After a Positive Fecal Test and Risk of Colorectal Cancer-Related Outcomes. Gastroenterology 04/2016;150(4):S45. DOI:10.1016/S0016-5085(16)30276-1
Ghai NR, Schottinger JE, Contreras R, Fischer H, Lee AT, Corley D, Doubeni CA, Jensen CD, Zauber AG, Levin TR, Quinn VP. Sa1082 Colorectal Cancer Screening Outreach Targeting Members Older than 75 Years of Age. Gastroenterology 04/2016;150(4):S234. DOI: 10.1016/S0016-5085(16)30855-1
Doubeni CA, Corley D, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson J, Mehta SJ, Becerra T, Zhao WK, Schottinger JE, Doria-Rose VP, Levin TR, Weiss N, Fletcher R. 251 Screening Colonoscopy and the Risk of Death From Right and Left Colon Cancers. Gastroenterology 04/2016;150(4):S61. DOI:10.1016/S0016-5085(16)30325-0
Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, Xu X, Barac A, Chlebowski RT. Cardiovascular Disease After Aromatase Inhibitor Use 04/2016; DOI:10.1001/jamaoncol.2016.0429